CEC Publications 2000

Breast Cancer

Hopper JL, Firgaira FA, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Seshadri R, McEvoy CR. Response: Re: HRAS1 rare minisatellite alleles and breast cancer in Australian women under age forty years [letter]. J Natl Cancer Inst. 2000;92:756-757

Huttley GA, Easteal S, Southey MC, Tesoriero A, Giles GG, McCredie MR, Hopper JL, Venter DJ. Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet. 2000;25:410-413

Kavanagh AM, Giles GG, Mitchell H, Cawson JN. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen. 2000;7:105-110

Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet. 2000;355:270-274

Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF. kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust. 2000;172:463-464

Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst. 2000;92:1674-1681

Prostate Cancer

Badzioch M, Eeles R, Leblanc G, Foulkes WD, Giles G, Edwards S, Goldgar D, Hopper JL, Bishop DT, Moller P, Heimdal K, Easton D, Simard J. Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators [letter]. J Med Genet. 2000;37:947-949

Frydenberg M, Giles GG, Mameghan H, Thursfield VJ, Millar J, Wheelahan JB, Bolton DM, Syme RR. Prostate cancer in Victoria in 1993: Patterns of reported management. Med J Aust. 2000;172:270-274

Singh R. No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed. Br J Cancer. 2000;83:1654-1658

Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet. 2000;66:945-957


Autier P, Dore JF, Reis AC, Grivegnee A, Ollivaud L, Truchetet F, Chamoun E, Rotmensz N, Severi G, Cesarini JP. Sunscreen use and intentional exposure to ultraviolet A and B radiation: A double blind randomized trial using personal dosimeters. Br J Cancer. 2000;83:1243-1248

Autier P, Severi G, Boyle P, Dore JF. Response more about: Sunscreen use and duration of sun exposure: A double-blind, randomized trial. J Natl Cancer Inst. 2000;92:1532-1533

Autier P, Severi G, Dore JF, Boniol M. Has the sun protection factor had its day? Information on sunscreens should warn against excessive sun exposure. Bmj. 2000;320:1274-1275

Marcil I SRS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Archives of Dermatology. 2000;136:1524-1530

Milne E, English DR, Johnston R, Cross D, Borland R, Costa C, Giles-Corti B. Improved sun protection behaviour in children after two years of the kidskin intervention. Aust N Z J Public Health. 2000;24:481-487

Plesko I, Severi G, Obsitnikova A, Boyle P. Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995. Neoplasma. 2000;47:137-142

Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: Evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-1891

Other Cancer

Richardson GE, Thursfield VJ, Giles GG. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust. 2000;172:321-324

Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Int J Cancer. 2000;87:637-643

Other Conditions

Deague JA, Wilson CM, Grigg LE, Harrap SB. Increased left ventricular mass is not associated with impaired left ventricular diastolic filling in normal individuals. J Hypertens. 2000;18:757-762

Ellis JA, Stebbing M, Harrap SB. Association of the human Y chromosome with high blood pressure in the general population. Hypertension. 2000;36:731-733

Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia. Brain. 2000;123 ( Pt 5):968-974

Hammond SR, McLeod JG, Macaskill P, English DR. Multiple sclerosis in Australia: Prognostic factors. J Clin Neurosci. 2000;7:16-19

Harrap SB. Cardiovascular disease: Genes and public health. Ann Acad Med Singapore. 2000;29:279-283

Harrap SB, Stebbing M, Hopper JL, Hoang HN, Giles GG. Familial patterns of covariation for cardiovascular risk factors in adults: The Victorian Family Heart Study. Am J

Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G. The Anti-Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health. 2000;24:576-583  

Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG. Impaired fasting glucose: How low should it go? Diabetes Care. 2000;23:34-39